Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 2,263† | 2,187† | 2,271† | 2,500† | 2,256† |
| Net profit | 169 | 157 | 142 | 153 | 195 |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Harit Pragji Shah | Executive Director | June 30, 2026 |
| Harshit Manilal Savla | Executive Director | June 30, 2026 |
| Prakash Moreshwar Patil | Executive Director | June 30, 2026 |
| Rashesh Chandrakant Gogri | Executive Director | June 30, 2026 |
| Uday Moreshwar Patil | Executive Director | June 30, 2026 |
| Ajit Eledath Venugopalan | Independent Director | June 30, 2026 |
| Ankit Vikram Paleja | Independent Director | June 30, 2026 |
| Bhaskar Narayan Thorat | Independent Director | June 30, 2026 |
| Hasmukh Bhavanji Dedhia | Independent Director | June 30, 2026 |
| Neha Rajen Gada | Independent Director | June 30, 2026 |
| Sandeep Madhusudan Joshi | Independent Director | June 30, 2026 |
| Narendra Jagannath Salvi | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
